产品
编 号：F065080
分子式：C22H27ClN4O5
分子量：462.93
分子式：C22H27ClN4O5
分子量：462.93
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
100mg
询价
询价
结构图
CAS No: 1191995-00-2
产品详情
生物活性：
Dorzagliatin (HMS5552), a dual-acting glucokinase (GK) activator, improves glycaemic control and pancreatic β-cell function in type 2 diabetes.
体内研究：
Dorzagliatin (低剂量 10 mg/kg，高剂量 30 mg/kg；胃内给药；每天上午 8:00，持续一个月) 对糖尿病大鼠的血糖水平产生降糖作用[2。Animal Model:Male Sprague-Dawley (SD) rats (aged approximately 6–8 weeks and weighing 200-230?g)[2
Dosage:Low-dose (10?mg/kg), and high-dose (30?mg/kg)
Administration:Administered intragastrically (i.g.); daily (8:00 AM) for one month
Result:Exerted a glucose-lowering effect on the glucose levels.
Dorzagliatin (HMS5552), a dual-acting glucokinase (GK) activator, improves glycaemic control and pancreatic β-cell function in type 2 diabetes.
体内研究：
Dorzagliatin (低剂量 10 mg/kg，高剂量 30 mg/kg；胃内给药；每天上午 8:00，持续一个月) 对糖尿病大鼠的血糖水平产生降糖作用[2。Animal Model:Male Sprague-Dawley (SD) rats (aged approximately 6–8 weeks and weighing 200-230?g)[2
Dosage:Low-dose (10?mg/kg), and high-dose (30?mg/kg)
Administration:Administered intragastrically (i.g.); daily (8:00 AM) for one month
Result:Exerted a glucose-lowering effect on the glucose levels.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备